MediQuest Therapeutics
Quick facts
Phase 3 pipeline
- Topical AmphiMatrix · Dermatology
Topical AmphiMatrix is a topical matrix formulation that combines multiple active ingredients to provide sustained release of therapeutic agents. - Topical organogel with nitroglycerin · Cardiovascular
Nitroglycerin releases nitric oxide to dilate blood vessels and improve blood flow when applied topically as an organogel formulation.
Phase 2 pipeline
- MQX-503
- Organogel of naftifine, 2%
- Organogel of naftifine, 6%
- Organogel of terbinafine, 2%
- Organogel of terbinafine, 6%
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: